The finding of an association between our significantly identified SNP in the Caucasian cohort with a glucocorticoid receptor site raises the possibility of a previously unrecognized therapeutic mechanism of these commonly used medications in the treatment of CRS. The gene discussed is NR3C1; the disease is congenital rubella syndrome.